France· FR:60833559
AFLAVIS 1 mg/mL, collyre en solution
A medicinal product, registered in France by LABORATOIRES DOLIAGE DEVELOPPEMENT, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- LABORATOIRES DOLIAGE DEVELOPPEMENT
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009301731381 flacon(s) polyéthylène basse densité (PEBD) de 5 ml avec embout(s) polyéthylène haute densité (PEHD) siliconé(e)EUR 5.58
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
AFLAVIS in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAxium-Opto 1mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A
- PolandDarazurPharmaselect International Beteiligungs GmbH
- SwedenAxiumopto 1 mg/ml Ögondroppar, lösning i endosbehållareUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
- NorwayMonopexLaboratoires Théa S.A.S
- SwitzerlandDexocol 1 mg/ml, collyre en solutionHorus Pharma Suisse SA
- IrelandDexafree 1 mg/ml eye drops, solution in single dose containerIMED Healthcare Ltd.
- IcelandOpnolKaro Pharma AB*
- FinlandIsopto-MaxidexAlcon Couvreur N.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dexamethason Hcs, Dexamethason Kalceks
- Belgium · Darazon, Dexalis
- Bulgaria · Dexanova, Дeксаметазон Крка
- Cyprus · Axium-Opto, Decadron
- Czechia · Dexamed, Dexamethasone Fmk
- Germany · Dexa, Dexa Edo
- Denmark · Axiumopto, Dexacur
- Estonia · Caltrixan, Dexamethason Krka
- Spain · Amexxine, Dexafree
- Finland · Axiumopto, Dexacur
- United Kingdom (Northern Ireland) · Dexafree, Dexamethason Glenmark Pharmaceuticals Europe
- Greece · Amelinor, Axium
- Croatia · Darazur, Deksametazon Kalceks
- Hungary · Darazur, Dexamethasone Kalceks
- Ireland · Dexafree, Dexamethasone Activase Pharmaceuticals
- Iceland · Dexametason Abcur, Dexamethason Krka
- Italy · Amexzur, Cortmuper
- Liechtenstein · Neofordex, Ozurdex
- Lithuania · Dexamethason Krka, Dexamethasone Kalceks
- Luxembourg · Dexalis, Dexamethasone Kalceks
- Latvia · Dexamethason Krka, Dexamethasone Kalceks
- Malta · Axium-Opto, Decadron
- Netherlands · Axium-Opto, Dexamethason
- Norway · Dexacur, Dexametason Abcur
- Poland · Covexan, Darazur
- Portugal · Amexzur, Decadron
- Romania · Dexametazonă Fosfat Krka, Dexametazona Krka
- Sweden · Axiumopto, Baxil
- Slovenia · Deksametazon Krka, Deksametazon Medochemie
- Slovakia · Amexxine, Dexametazón Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/77d95584-50ef-4cc5-ba17-78123234670f GET /v1/drugs/77d95584-50ef-4cc5-ba17-78123234670f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60833559",
"date_amm": "2019-02-25",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about AFLAVIS.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.